Insulin pump-associated adverse events in children and adolescents - A prospective study

Diabetes Technology and Therapeutics

Volumn 16, Issue 9, 2014, Pages 558-562

  Wheeler, Benjamin J ^a,b   Heels, Kristine ^a   Donaghue, Kim C ^a,c   Reith, David M ^b   Ambler, Geoffrey R ^a,c  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; INSULIN; ANTIDIABETIC AGENT;

ADOLESCENT; ARTICLE; BATTERY ISSUE; CHILD; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE DURATION; EMERGENCY WARD; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; INFREQUENT CHANGE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN PUMP; INTERVIEW; KEY PAD FAILURE; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE COMPLICATION; PREMATURE SITE FAILURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUMP INSULIN LEAK; PUMP MECHANICAL PROBLEM; SCHOOL CHILD; ADVERSE EFFECTS; AGE; AUSTRALIA; DEVICE FAILURE; DIABETES MELLITUS, TYPE 1; EDUCATION; EMERGENCY HEALTH SERVICE; HEALTH LITERACY; HOSPITALIZATION; INCIDENCE; INFUSION PUMP; PARENT; PATIENT EDUCATION; PSYCHOLOGY; QUESTIONNAIRE; RISK FACTOR; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

ADOLESCENT; AGE FACTORS; AUSTRALIA; CHILD; DIABETES MELLITUS, TYPE 1; EMERGENCY SERVICE, HOSPITAL; EQUIPMENT FAILURE; FEMALE; HEALTH LITERACY; HOSPITALIZATION; HUMANS; HYPOGLYCEMIC AGENTS; INCIDENCE; INFUSION PUMPS, IMPLANTABLE; INSULIN; MALE; PARENTS; PATIENT EDUCATION AS TOPIC; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; TREATMENT OUTCOME;

EID: 84906344228     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2013.0388     Document Type: Article

References (18)

1. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329:977-986.
2. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B: Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005;353:2643-2653.
3. Craig ME, Twigg SM, Donaghue KC, Cheung NW, Cameron FJ, Conn J, Jenkins AJ, Silink M, for the Australian Type 1 Diabetes Guidelines Expert Advisory Group: National Evidence-Based Clinical Care Guidelines for Type 1 Diabetes in Children, Adolescents and Adults. Canberra: Australian Government Department of Health and Ageing, 2011.
4. Pankowska E, Blazik M, Dziechciarz P, Szypowska A, Szajewska H: Continuous subcutaneous insulin infusion vs. multiple daily injections in children with type 1 diabetes: a systematic review and meta-analysis of randomized control trials. Pediatr Diabetes 2009;10:52-58.
5. Misso ML, Egberts KJ, Page M, O'Connor D, Shaw J: Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus. Cochrane Database Syst Rev 2010;(1):CD005103.
6. Bolli GB, Kerr D, Thomas R, Torlone E, Sola-Gazagnes A, Vitacolonna E, Selam JL, Home PD: Comparison of a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) in type 1 diabetes: a randomized open parallel multicenter study. Diabetes Care 2009;32: 1170-1176.
7. Fatourechi MM, Kudva YC, Murad MH, Elamin MB, Tabini CC, Montori VM: Clinical review: Hypoglycemia with intensive insulin therapy: a systematic review and metaanalyses of randomized trials of continuous subcutaneous insulin infusion versus multiple daily injections. J Clin Endocrinol Metab 2009;94:729-740.
8. Cooper MN, O'Connell SM, Davis EA, Jones TW: A population-based study of risk factors for severe hypoglycaemia in a contemporary cohort of childhood-onset type 1 diabetes. Diabetologia 2013;56:2164-2170.
9. Wheeler BJ, Donaghue KC, Heels K, Ambler GR: Family perceptions of insulin pump adverse events in children and adolescents. Diabetes Technol Ther 2014;16:204-207.
10. Mecklenburg RS, Benson EA, Benson JW Jr, Fredlund PN, Guinn T, Metz RJ, Nielsen RL, Sanner CA: Acute complications associated with insulin infusion pump therapy. Report of experience with 161 patients. JAMA 1984;252: 3265-3269.
11. Cope JU, Samuels-Reid JH, Morrison AE: Pediatric use of insulin pump technology: a retrospective study of adverse events in children ages 1-12 years. J Diabetes Sci Technol 2012;6:1053-1059.
12. Cope JU, Morrison AE, Samuels-Reid J: Adolescent use of insulin and patient-controlled analgesia pump technology: a 10-year Food and Drug Administration retrospective study of adverse events. Pediatrics 2008;121:e1133-e1138.
13. Wood JR, Moreland EC, Volkening LK, Svoren BM, Butler DA, Laffel LM: Durability of insulin pump use in pediatric patients with type 1 diabetes. Diabetes Care 2006; 29:2355-2360.
14. Renard E, Guerci B, Leguerrier AM, Boizel R; Accu-Chek FlexLink Study Group: Lower rate of initial failures and reduced occurrence of adverse events with a new catheter model for continuous subcutaneous insulin infusion: prospective, two-period, observational, multicenter study. Diabetes Technol Ther 2010;12:769-773.
15. Zhang Y, Jones PL, Klonoff DC: Second Insulin Pump Safety Meeting: summary report. J Diabetes Sci Technol 2010;4:488-493.
16. Skinner TC, Cameron FJ: Improving glycaemic control in children and adolescents: which aspects of therapy really matter? Diabet Med 2010;27:369-375.
17. Ducharme FM, Zemek RL, Chalut D, McGillivray D, Noya FJ, Resendes S, Khomenko L, Rouleau R, Zhang X: Written action plan in pediatric emergency room improves asthma prescribing, adherence, and control. Am J Respir Crit Care Med 2011;183:195-203.
18. Deis JN, Spiro DM, Jenkins CA, Buckles TL, Arnold DH: Parental knowledge and use of preventive asthma care measures in two pediatric emergency departments. J Asthma 2010;47:551-556.